mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.05 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.11 |
0.06 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.06 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.06 |